Ads
related to: generic drug companies stocksinvesco.com has been visited by 1M+ users in the past month
Search results
Can You Get Ozempic at Costco? See How to Save on Weight Loss Drugs
Motley Fool via Yahoo Finance· 2 days agoSome major food and beverage companies saw big declines in theirstock prices because of Ozempic,...
Amphastar maintains stock target on AMP-008 FDA approval By Investing.com
Investing.com· 2 days agoOn Thursday, Piper Sandler confirmed its Overweight rating and a $71.00 stock price target for...
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
InvestorPlace· 5 days agoHims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable...
Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?
Zacks via Yahoo Finance· 1 day agoCurrently, Supernus is a Zacks Rank #3 (Hold) in the Medical - Generic Drugs industry that ranks in...
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than...
Fortune· 5 days agoHims said it’s offering a treatment with the same active ingredient as Wegovy for $199 a month. This will help customers access these drugs without “navigating the shortages and costs that are ...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
INSIDER via Yahoo News· 5 days agoHims & Hers' stock surged more than 30% on Monday in response to the news...brand-name versions —...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks· 6 days agoFree Report) boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda approved for several types of cancer and alone accounting for more than 45% of the
Midcap stock jumps 4% after company signs supply agreement with Korean based company
Investing.com· 2 days agoPharma Stock engaged in the business of manufacture and distribution of biotechnology products and...
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Zacks via Yahoo Finance· 5 days agocompany registered earnings growth of 14.7% compared with the industry’s 12.7% rise. The company’s...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 3 days agoBMS is dealing with the loss of patent protection...s why contrarian investors may want to scoop up this unpopular dividend stock right now. Bristol...
